Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.
Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check5 days agoChange DetectedDifference0.2%
- Check12 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.9%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference4%
- Check26 days agoChange DetectedDifference2%
- Check33 days agoChange DetectedSeveral links related to genetic conditions and rare diseases have been removed, including those for Ewing sarcoma, neuroblastoma, and glioblastoma, which may impact access to important information on these topics.SummaryDifference6%
- Check41 days agoChange DetectedNew resources related to various cancers, including Ewing sarcoma, neuroblastoma, and glioblastoma, have been added to the website, enhancing information availability on rare diseases.SummaryDifference1%
Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.